Long-term consequences of COVID-19 in hospitalized patients over 75 years old

Abstract

BACKGROUND: The COVID-19 pandemic remains an urgent medical and socio-economic problem. The symptoms, signs and complications of COVID-19 in the acute phase of the disease are now well known, while the long-term consequences of the disease continue to be studied.

AIM: The aim of this study was to study the frequency, clinical manifestations of “prolonged” COVID-19 and post-covid syndrome in advanced and old ages people treated in a hospital.

MATERIALS AND METHODS: The study included patients aged over 75 years old diagnosed with COVID-19 who were treated in two multidisciplinary hospitals in Moscow in 2021–2022: 94 patients aged 75 to 94 years, including 75.5% of women. At the stage of inpatient treatment, patients were interviewed and medical records were analyzed with registration of demographic data, comorbidities, clinical symptoms and signs of the disease, laboratory markers, complications, and treatment outcome. After 1 and 12 months. after discharge, among the survivors, they were interviewed by telephone interview using a special questionnaire with registration of complaints, repeated hospitalizations and complications of COVID-19, assessment of their psycho-emotional state and identification of cognitive-behavioral disorders.

RESULTS: In 70.2% of cases, the disease proceeded in a severe and extremely severe form. The majority of patients before COVID-19 had chronic diseases, most often arterial hypertension (85.9%), chronic heart failure (45.7%) and diabetes mellitus (27.2%). Hospital mortality was 22.6%. Poll after 1 month performed in 41/70 surviving patients (58.6%). Among the symptoms, the most common were fainting (41.5%), palpitations (36.6%), constipation (34.1%), the appearance or increase of shortness of breath (31.7%). Almost every day, 14.6%, 12.2% and 14.6% of the respondents experienced stress, anxiety and apathy. Difficulties in performing hygiene procedures, self-care, dressing were observed in 19.5, 12.2 and 12.2% of cases, respectively; 36.6% experienced severe problems when walking long distances. Poll after 12 months performed in 34/70 people (51.4%). Among the symptoms, the most frequently recorded were behavioral changes (32.4%), increased blood pressure (26.5%), problems with vision (26.5%) and hearing (23.5%). Psycho-emotional disorders were detected less frequently: 2 patients (5.9%) experienced daily stress, 1 respondent (2.9%) was worried about strong agitation and apathy. Difficulties in dressing, performing hygiene procedures, self-care were experienced by 32.4, 29.4 and 8.8% of patients; 20.6% experienced severe problems when walking long distances.

CONCLUSIONS: The conducted study indicates a high prevalence of symptoms of “prolonged” COVID-19 and post-covid syndrome in elderly people and the duration of their persistence, which may limit their functional activity and negatively affect the quality of life.

Keywords

post-COVID syndrome / multiple organ failures / late adulthood

References

[1] Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á, et al. Post-COVID-19 syndrome and the potential benefits of exercise. Int J Environ Res Public Health. 2021;18:5329. DOI: 10.3390/ijerph18105329

[2] Jimeno-Almazán A., Pallarés J.G., Buendía-Romero Á. et al. Post-COVID-19 syndrome and the potential benefits of exercise // Int. J. Environ. Res. Public Health. 2021. Vol. 18. P. 5329. DOI: 10.3390/ijerph18105329

[3] Khasanova DR, Zhitkova YuV, Vaskaeva GR. Post-covid syndrome: a review of pathophysiology, neuropsychiatric manifestations and treatment perspectives. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(3):93–98. (In Russ.) DOI: 10.14412/2074-2711-2021-3-93-98

[4] Хасанова Д.Р., Житкова Ю.В., Васкаева Г.Р. Постковидный синдром: обзор знаний о патогенезе, нейропсихиатрических проявлениях и перспективах лечения // Неврология, нейропсихиатрия, психосоматика. 2021. № 13. С. 93–98. DOI: 10.14412/2074-2711-2021-3-93-98

[5] Amirov NB, Davletshina EI, Vasilyeva AG, Fatykhov RG. Postcovid syndrome: multisystem “deficits”. Bulletin of Contemporary Clinical Medicine. 2021;14(6):94–104. (In Russ.) DOI: 10.20969/VSKM.2021.14(6).94-104

[6] Амиров Н.Б., Давлетшина Э.И., Васильева А.Г., Фатыхов Р.Г. Постковидный синдром: мультисистемные «дефициты» // Вестник современной клинической медицины. 2021. Т. 14, № 6. С. 94–104. DOI: 10.20969/VSKM.2021.14(6).94-104

[7] De Virgiliis F, Di Giovanni S. Lung innervation in the eye of a cytokine storm: Neuroimmune interactions and COVID-19. Nat Rev Neurol. 2020;16(11):645–652. DOI: 10.1038/s41582-020-0402-y

[8] De Virgiliis F., Di Giovanni S. Lung innervation in the eye of a cytokine storm: Neuroimmune interactions and COVID-19 // Nat. Rev. Neurol. 2020. Vol. 16, No. 11. P. 645–652. DOI: 10.1038/s41582-020-0402-y

[9] Michel JP, Maggi S, Ecarnot F. Raising awareness of the needs of older COVID patients after hospital discharge. Aging Clin Exp Res. 2020;32(8):1595–1598. DOI: 10.1007/s40520-020-01620-1

[10] Michel J.P., Maggi S., Ecarnot F. Raising awareness of the needs of older COVID patients after hospital discharge // Aging Clin. Exp. Res. 2020. Vol. 32, No. 8. P. 1595–1598. DOI: 10.1007/s40520-020-01620-1

[11] Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782–793. DOI: 10.1001/jama.2020.12839

[12] Wiersinga W.J., Rhodes A., Cheng A.C. et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review // JAMA. 2020. Vol. 324. P. 782–793. DOI: 10.1001/jama.2020.12839

[13] Cevik M, Kuppalli K, Kindrachuk J, Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020;371:m3862. DOI: 10.1136/bmj.m3862

[14] Cevik M., Kuppalli K., Kindrachuk J., Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2 // BMJ. 2020. Vol. 371. P. m3862. DOI: 10.1136/bmj.m3862

[15] Salamanna F, Veronesi F, Martini L, et al. Post-COVID-19 syndrome: The persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med (Lausanne). 2021;8:653516. DOI: 10.3389/fmed.2021.653516

[16] Salamanna F., Veronesi F., Martini L. et al. Post-COVID-19 syndrome: The persistent symptoms at the post-viral stage of the disease. A systematic review of the current data // Front. Med. (Lausanne). 2021. Vol. 8. P. 653516. DOI: 10.3389/fmed.2021.653516

[17] Truffaut L, Demey L, Bruyneel AV, et al. Post-discharge critical COVID-19 lung function related to severity of radiologic lung involvement at admission. Respir Res. 2021;22(1):29. DOI: 10.1186/s12931-021-01625-y

[18] Truffaut L., Demey L., Bruyneel A.V. et al. Post-discharge critical COVID-19 lung function related to severity of radiologic lung involvement at admission // Respir. Res. 2021. Vol. 22, No. 1. P. 29. DOI: 10.1186/s12931-021-01625-y

[19] Jaffri A, Jaffri UA. Post-Intensive care syndrome and COVID-19: crisis after a crisis? Heart Lung. 2020;49(6):883–884. DOI: 10.1016/j.hrtlng.2020.06.006

[20] Jaffri A., Jaffri U.A. Post-Intensive care syndrome and COVID-19: crisis after a crisis? // Heart Lung. 2020. Vol. 49, No. 6. P. 883–884. DOI: 10.1016/j.hrtlng.2020.06.006

[21] Higgins V, Sohaei D, Diamandis EP, et al. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2021;58(5):297–310. DOI: 10.1080/10408363.2020.1860895

[22] Higgins V., Sohaei D., Diamandis E.P. et al. COVID-19: from an acute to chronic disease? Potential long-term health consequences // Crit. Rev. Clin. Lab. Sci. 2021. Vol. 58, No. 5. P. 297–310. DOI: 10.1080/10408363.2020.1860895

[23] Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53:737–754. DOI: 10.1080/23744235.2021.1924397

[24] Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments // Infect. Dis. (Lond). 2021. Vol. 53. P. 737–754. DOI: 10.1080/23744235.2021.1924397

[25] O’Sullivan O. Long-term sequelae following previous coronavirus epidemics. Clin Med (Lond). 2021;21(1):e68–e70. DOI: 10.7861/clinmed.2020-0204

[26] O’Sullivan O. Long-term sequelae following previous coronavirus epidemics // Clin. Med. (Lond). 2021. Vol. 21, No. 1. P. e68–e70. DOI: 10.7861/clinmed.2020-0204

[27] Michel JP, Maggi S, Ecarnot F. Raising awareness of the needs of older COVID patients after hospital discharge. Aging Clin Exp Res. 2020;32(8):1595–1598. DOI: 10.1007/s40520-020-01620-1

[28] Michel J.P., Maggi S., Ecarnot F. Raising awareness of the needs of older COVID patients after hospital discharge // Aging Clin. Exp. Res. 2020. Vol. 32, No. 8. P. 1595–1598. DOI: 10.1007/s40520-020-01620-1

[29] Tsamakis K, Tsiptsios D, Ouranidis A, et al. COVID-19 and its consequences on mental health (Review). Exp Ther Med. 2021;21(3):244. DOI: 10.3892/etm.2021.9675

[30] Tsamakis K., Tsiptsios D., Ouranidis A. et al. COVID-19 and its consequences on mental health (Review) // Exp. Ther. Med. 2021. Vol. 21, No. 3. P. 244. DOI: 10.3892/etm.2021.9675

[31] Liu D, Baumeister RF, Zhou Y. Mental health outcomes of coronavirus infection survivors: A rapid meta-analysis. J Psychiatr Res. 2021;137:542–553. DOI: 10.1016/j.jpsychires.2020.10.015

[32] Liu D., Baumeister R.F., Zhou Y. Mental health outcomes of coronavirus infection survivors: A rapid meta-analysis // J. Psychiatr. Res. 2021. Vol. 137. P. 542–553. DOI: 10.1016/j.jpsychires.2020.10.015

[33] Walle-Hansen MM, Ranhoff AH, Mellingsæter M, et al. Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19. BMC Geriatr. 2021;21:199. DOI: 10.1186/s12877-021-02140-x

[34] Walle-Hansen M.M., Ranhoff A.H., Mellingsæter M. et al. Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19 // BMC Geriatr. 2021. Vol. 21. P. 199. DOI: 10.1186/s12877-021-02140-x

[35] Covino M, Russo A, Salini S, et al. Long-term effects of hospitalization for COVID-19 on frailty and quality of life in older adults ≥80 years. J Clin Med. 2022;11(19):5787. DOI: 10.3390/jcm11195787

[36] Covino M., Russo A., Salini S. et al. Long-term effects of hospitalization for COVID-19 on frailty and quality of life in older adults ≥80 years // J. Clin. Med. 2022. Vol. 11, No. 19. P. 5787. DOI: 10.3390/jcm11195787

[37] Gaebler C, Wang Z, Lorenzi JCC, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639–644. DOI: 10.1038/s41586-021-03207-w

[38] Gaebler C., Wang Z., Lorenzi J.C.C. et al. Evolution of antibody immunity to SARS-CoV-2 // Nature. 2021. Vol. 591, No. 7851. P. 639–644. DOI: 10.1038/s41586-021-03207-w

[39] Wang EY, Mao T, Klein J, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283–288. DOI: 10.1101/2020.12.10.20247205

[40] Wang E.Y., Mao T., Klein J. et al. Diverse functional autoantibodies in patients with COVID-19 // Nature. 2021. Vol. 595, No. 7866. P. 283–288. DOI: 10.1101/2020.12.10.20247205

[41] Zuo Y, Estes SK, Ali RA, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020;12(570):eabd3876. DOI: 10.1126/scitranslmed.abd3876

[42] Zuo Y., Estes S.K., Ali R.A. et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19 // Sci. Transl. Med. 2020. Vol. 12, No. 570. P. eabd3876. DOI: 10.1126/scitranslmed.abd3876

[43] Thompson EA, Cascino K, Ordonez AA, et al. Metabolic programs define dysfunctional immune responses in severe COVID-19 patients. Cell Rep. 2021;34(11):108863. DOI: 10.1016/j.celrep.2021.108863

[44] Thompson E.A., Cascino K., Ordonez A.A. et al. Metabolic programs define dysfunctional immune responses in severe COVID-19 patients // Cell Rep. 2021. Vol. 34, No. 11. P. 108863. DOI: 10.1016/j.celrep.2021.108863

[45] Ajaz S, McPhail MJ, Singh KK, et al. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am J Physiol Cell Physiol. 2021;320(1):C57–C65. DOI: 10.1152/ajpcell.00426.2020

[46] Ajaz S., McPhail M.J., Singh K.K. et al. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19 // Am. J. Physiol. Cell Physiol. 2021. Vol. 320, No. 1. P. C57–C65. DOI: 10.1152/ajpcell.00426.2020

[47] Naviaux RK, Naviaux JC, Li K, et al. Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci USA. 2016;113(37):E5472–5480. DOI: 10.1073/pnas.1607571113

[48] Naviaux R.K., Naviaux J.C., Li K. et al. Metabolic features of chronic fatigue syndrome // Proc. Natl. Acad. Sci. USA. 2016. Vol. 113, No. 37. P. E5472–5480. DOI: 10.1073/pnas.1607571113

[49] Ni W, Yang X, Yang D, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020;24(1):422. DOI: 10.1186/s13054-020-03120-0

[50] Ni W., Yang X., Yang D. et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 // Crit. Care. 2020. Vol. 24, No. 1. P. 422. DOI: 10.1186/s13054-020-03120-0

RIGHTS & PERMISSIONS

Eco-Vector